Loading...
Allakos reported a net loss of $18.4 million for the third quarter of 2024, with cash, cash equivalents, and investments totaling $92.7 million. Research and development expenses were $10.9 million, and general and administrative expenses were $8.9 million.
Ended Q3 2024 with $92.7 million in cash, cash equivalents and investments.
Net decrease in cash, cash equivalents and investments of $30.4 million during Q3 2024.
Research and development expenses were $10.9 million in Q3 2024.
Reported a net loss of $18.4 million in Q3 2024.
Analyze how earnings announcements historically affect stock price performance